320 related articles for article (PubMed ID: 25952784)
21. Biomarkers for personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2015 Mar; 64(3 Suppl 1):S16-21. PubMed ID: 25468140
[TBL] [Abstract][Full Text] [Related]
22. New advances in genitourinary cancer: evidence gathered in 2014.
Suárez C; Puente J; Gallardo E; Méndez-Vidal MJ; Climent MA; León L; Olmos D; García del Muro X; González-Billalabeitia E; Grande E; Bellmunt J; Mellado B; Maroto P; González del Alba A
Cancer Metastasis Rev; 2015 Sep; 34(3):443-64. PubMed ID: 26227584
[TBL] [Abstract][Full Text] [Related]
23. Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.
Knepper TC; Bell GC; Hicks JK; Padron E; Teer JK; Vo TT; Gillis NK; Mason NT; McLeod HL; Walko CM
Oncologist; 2017 Feb; 22(2):144-151. PubMed ID: 28179575
[TBL] [Abstract][Full Text] [Related]
24. An overview of the NCI precision medicine trials-NCI MATCH and MPACT.
Do K; O'Sullivan Coyne G; Chen AP
Chin Clin Oncol; 2015 Sep; 4(3):31. PubMed ID: 26408298
[TBL] [Abstract][Full Text] [Related]
25. [Molecular-Genetic Diagnosis and Molecular-Targeted Therapy in Cancer: Challenges in the Era of Precision Medicine].
Miyachi H
Rinsho Byori; 2015 Oct; 63(10):1188-93. PubMed ID: 26897855
[TBL] [Abstract][Full Text] [Related]
26. Biologic tools to personalize treatment in genitourinary cancers.
Bracarda S; Sisani M; Del Buono S; Ishiwa O; Montagnani F;
Crit Rev Oncol Hematol; 2012 Dec; 84 Suppl 1():e42-8. PubMed ID: 21232974
[TBL] [Abstract][Full Text] [Related]
27. Adaptive Immunity in Genitourinary Cancers.
Koti M; Bivalacqua T; Black PC; Cathomen T; Galsky MD; Gulley JL; Ingersoll MA; Kamat AM; Kassouf W; Siemens DR; Gao J
Eur Urol Oncol; 2023 Jun; 6(3):263-272. PubMed ID: 37069029
[TBL] [Abstract][Full Text] [Related]
28. Genitourinary Tumors: Update on Molecular Biomarkers for Diagnosis, Prognosis and Prediction of Response to Therapy.
Cimadamore A; Scarpelli M; Santoni M; Massari F; Tartari F; Cerqueti R; Lopez-Beltran A; Cheng L; Montironi R
Curr Drug Metab; 2019; 20(4):305-312. PubMed ID: 30799789
[TBL] [Abstract][Full Text] [Related]
29. Genomic Sequencing Should Not be Part of the Standard of Care for Most Urologic Cancers.
Abern MR; Dudinec JV; Inman BA
Eur Urol Focus; 2022 May; 8(3):639-640. PubMed ID: 35537938
[TBL] [Abstract][Full Text] [Related]
30. Pediatric genitourinary tumors.
Buckley KS
Curr Opin Oncol; 2011 May; 23(3):297-302. PubMed ID: 21460723
[TBL] [Abstract][Full Text] [Related]
31. Prostate cancer molecular profiling: the Achilles heel for the implementation of precision medicine.
Oliveira-Barros EG; Nicolau-Neto P; Da Costa NM; Pinto LFR; Palumbo A; Nasciutti LE
Cell Biol Int; 2017 Nov; 41(11):1239-1245. PubMed ID: 28477422
[TBL] [Abstract][Full Text] [Related]
32. Pediatric genitourinary tumors.
McLean TW; Buckley KS
Curr Opin Oncol; 2010 May; 22(3):268-73. PubMed ID: 20168230
[TBL] [Abstract][Full Text] [Related]
33. Pediatric genitourinary tumors.
Herz D; McLellan D; Garrels K; Merguerian PA
Curr Opin Oncol; 2000 May; 12(3):273-81. PubMed ID: 10841201
[TBL] [Abstract][Full Text] [Related]
34. Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives.
Zhou L; Wang K; Li Q; Nice EC; Zhang H; Huang C
Expert Rev Proteomics; 2016; 13(4):367-81. PubMed ID: 26923776
[TBL] [Abstract][Full Text] [Related]
35. Syndromes that Link the Endocrine System and Genitourinary Tract.
Özlük Y; Kılıçaslan I
Turk Patoloji Derg; 2015; 31 Suppl 1():155-71. PubMed ID: 26177325
[TBL] [Abstract][Full Text] [Related]
36. Personalized Cardiovascular Medicine Today: A Food and Drug Administration/Center for Drug Evaluation and Research Perspective.
Blaus A; Madabushi R; Pacanowski M; Rose M; Schuck RN; Stockbridge N; Temple R; Unger EF
Circulation; 2015 Oct; 132(15):1425-32. PubMed ID: 26459078
[TBL] [Abstract][Full Text] [Related]
37. Emerging Bladder Cancer Biomarkers and Targets of Therapy.
Netto GJ; Tafe LJ
Urol Clin North Am; 2016 Feb; 43(1):63-76. PubMed ID: 26614029
[TBL] [Abstract][Full Text] [Related]
38. The emerging role of circulating tumor cell detection in genitourinary cancer.
Small AC; Gong Y; Oh WK; Hall SJ; van Rijn CJ; Galsky MD
J Urol; 2012 Jul; 188(1):21-6. PubMed ID: 22578722
[TBL] [Abstract][Full Text] [Related]
39. Pathways to personalized medicine for breast and prostate cancers: emerging diagnostic methods and prognostic biomarkers.
Watson AP; Egland KA
S D Med; 2010 Jul; 63(7):247-53. PubMed ID: 20666024
[TBL] [Abstract][Full Text] [Related]
40. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]